Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. engages provision of home medical devices, medical clinical products, and related services in China and internationally. It offers respiratory solutions, including PAP therapy, oxygen concentrators, nebulizers, high flow oxygen therapy, and airway clearances; diabetes management solutions; medical diagnostic devices, such as blood pressure monito… Read more
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) - Net Assets
Latest net assets as of September 2025: CN¥13.64 Billion CNY
Based on the latest financial reports, Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) has net assets worth CN¥13.64 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥16.67 Billion) and total liabilities (CN¥3.04 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥13.64 Billion |
| % of Total Assets | 81.79% |
| Annual Growth Rate | 26.58% |
| 5-Year Change | 68.84% |
| 10-Year Change | 493.48% |
| Growth Volatility | 49.28 |
Jiangsu Yuyue Medical Equipment & Supply Co Ltd - Net Assets Trend (2005–2024)
This chart illustrates how Jiangsu Yuyue Medical Equipment & Supply Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Jiangsu Yuyue Medical Equipment & Supply Co Ltd (2005–2024)
The table below shows the annual net assets of Jiangsu Yuyue Medical Equipment & Supply Co Ltd from 2005 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥12.65 Billion | +6.20% |
| 2023-12-31 | CN¥11.92 Billion | +18.37% |
| 2022-12-31 | CN¥10.07 Billion | +19.42% |
| 2021-12-31 | CN¥8.43 Billion | +12.47% |
| 2020-12-31 | CN¥7.49 Billion | +21.74% |
| 2019-12-31 | CN¥6.16 Billion | +11.04% |
| 2018-12-31 | CN¥5.54 Billion | -0.47% |
| 2017-12-31 | CN¥5.57 Billion | +12.97% |
| 2016-12-31 | CN¥4.93 Billion | +131.27% |
| 2015-12-31 | CN¥2.13 Billion | +21.04% |
| 2014-12-31 | CN¥1.76 Billion | +16.13% |
| 2013-12-31 | CN¥1.52 Billion | +15.66% |
| 2012-12-31 | CN¥1.31 Billion | +18.44% |
| 2011-12-31 | CN¥1.11 Billion | +25.91% |
| 2010-12-31 | CN¥879.47 Million | +82.27% |
| 2009-12-31 | CN¥482.51 Million | +18.94% |
| 2008-12-31 | CN¥405.69 Million | +196.10% |
| 2007-12-31 | CN¥137.01 Million | -11.14% |
| 2006-12-31 | CN¥154.18 Million | +7.32% |
| 2005-12-31 | CN¥143.67 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Jiangsu Yuyue Medical Equipment & Supply Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 15759.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥9.02 Billion | 71.92% |
| Common Stock | CN¥1.00 Billion | 8.00% |
| Other Comprehensive Income | CN¥828.00 Million | 6.61% |
| Other Components | CN¥1.69 Billion | 13.48% |
| Total Equity | CN¥12.54 Billion | 100.00% |
Jiangsu Yuyue Medical Equipment & Supply Co Ltd Competitors by Market Cap
The table below lists competitors of Jiangsu Yuyue Medical Equipment & Supply Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
The Marzetti Company
NASDAQ:MZTI
|
$2.79 Billion |
|
QUILTER PLC 144A LS08167
F:2FQ0
|
$2.80 Billion |
|
ASSECO POLAND GDR/1 ZY 1
F:SFBG
|
$2.80 Billion |
|
TOHOKU EL. PWR CO.
F:TKT
|
$2.80 Billion |
|
Varonis Systems
NASDAQ:VRNS
|
$2.79 Billion |
|
LXP Industrial Trust
NYSE:LXP
|
$2.79 Billion |
|
Bank of Queensland Ltd
AU:BOQ
|
$2.79 Billion |
|
KBC Ancora
BR:KBCA
|
$2.79 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Jiangsu Yuyue Medical Equipment & Supply Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 11,763,562,138 to 12,535,332,607, a change of 771,770,469 (6.6%).
- Net income of 1,805,700,659 contributed positively to equity growth.
- Dividend payments of 1,224,455,405 reduced retained earnings.
- Other comprehensive income increased equity by 86,974,228.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥1.81 Billion | +14.4% |
| Dividends Paid | CN¥1.22 Billion | -9.77% |
| Other Comprehensive Income | CN¥86.97 Million | +0.69% |
| Other Changes | CN¥103.55 Million | +0.83% |
| Total Change | CN¥- | 6.56% |
Book Value vs Market Value Analysis
This analysis compares Jiangsu Yuyue Medical Equipment & Supply Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.85x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 318.29x to 2.85x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | CN¥0.11 | CN¥35.83 | x |
| 2006-12-31 | CN¥0.14 | CN¥35.83 | x |
| 2007-12-31 | CN¥0.24 | CN¥35.83 | x |
| 2008-12-31 | CN¥0.51 | CN¥35.83 | x |
| 2009-12-31 | CN¥0.57 | CN¥35.83 | x |
| 2010-12-31 | CN¥1.01 | CN¥35.83 | x |
| 2011-12-31 | CN¥1.62 | CN¥35.83 | x |
| 2012-12-31 | CN¥1.49 | CN¥35.83 | x |
| 2013-12-31 | CN¥1.73 | CN¥35.83 | x |
| 2014-12-31 | CN¥2.00 | CN¥35.83 | x |
| 2015-12-31 | CN¥2.40 | CN¥35.83 | x |
| 2016-12-31 | CN¥5.21 | CN¥35.83 | x |
| 2017-12-31 | CN¥5.22 | CN¥35.83 | x |
| 2018-12-31 | CN¥5.49 | CN¥35.83 | x |
| 2019-12-31 | CN¥6.06 | CN¥35.83 | x |
| 2020-12-31 | CN¥7.42 | CN¥35.83 | x |
| 2021-12-31 | CN¥8.31 | CN¥35.83 | x |
| 2022-12-31 | CN¥9.95 | CN¥35.83 | x |
| 2023-12-31 | CN¥11.83 | CN¥35.83 | x |
| 2024-12-31 | CN¥12.57 | CN¥35.83 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Jiangsu Yuyue Medical Equipment & Supply Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.40%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 23.87%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 1.25x
- Recent ROE (14.40%) is below the historical average (19.33%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 52.00% | 27.65% | 0.66x | 2.83x | CN¥47.47 Million |
| 2006 | 21.86% | 13.60% | 0.59x | 2.73x | CN¥17.12 Million |
| 2007 | 27.56% | 13.08% | 1.07x | 1.97x | CN¥24.13 Million |
| 2008 | 15.23% | 15.41% | 0.89x | 1.11x | CN¥21.24 Million |
| 2009 | 21.14% | 18.69% | 0.84x | 1.34x | CN¥52.99 Million |
| 2010 | 18.45% | 18.20% | 0.83x | 1.22x | CN¥73.69 Million |
| 2011 | 20.61% | 19.48% | 0.90x | 1.18x | CN¥116.58 Million |
| 2012 | 18.76% | 18.60% | 0.85x | 1.18x | CN¥113.95 Million |
| 2013 | 17.13% | 18.12% | 0.79x | 1.20x | CN¥107.41 Million |
| 2014 | 16.97% | 17.66% | 0.79x | 1.22x | CN¥121.98 Million |
| 2015 | 17.22% | 17.32% | 0.72x | 1.38x | CN¥152.76 Million |
| 2016 | 10.18% | 18.93% | 0.45x | 1.18x | CN¥8.86 Million |
| 2017 | 11.30% | 16.72% | 0.53x | 1.26x | CN¥67.93 Million |
| 2018 | 13.30% | 17.38% | 0.61x | 1.26x | CN¥180.34 Million |
| 2019 | 12.40% | 16.23% | 0.58x | 1.31x | CN¥145.51 Million |
| 2020 | 23.65% | 26.15% | 0.67x | 1.35x | CN¥1.02 Billion |
| 2021 | 17.92% | 21.50% | 0.57x | 1.45x | CN¥655.21 Million |
| 2022 | 16.18% | 22.46% | 0.47x | 1.53x | CN¥609.04 Million |
| 2023 | 20.37% | 30.05% | 0.50x | 1.36x | CN¥1.22 Billion |
| 2024 | 14.40% | 23.87% | 0.48x | 1.25x | CN¥552.17 Million |
Industry Comparison
This section compares Jiangsu Yuyue Medical Equipment & Supply Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,034,980,419
- Average return on equity (ROE) among peers: 25.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | CN¥13.64 Billion | 52.00% | 0.22x | $2.79 Billion |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |